1. Busse, Kathy, Strotmann, Rainer, Strecker, Karl, Schöneberg, Torsten, Schwarz, Johannes. 2014. Adaptive gene regulation in the Striatum of RGS9-deficient mice. In PloS one, 9, e92605. doi:10.1371/journal.pone.0092605. https://pubmed.ncbi.nlm.nih.gov/24663062/
2. Terzi, Dimitra, Gaspari, Sevasti, Manouras, Lefteris, Mitsi, Vassiliki, Zachariou, Venetia. 2014. RGS9-2 modulates sensory and mood related symptoms of neuropathic pain. In Neurobiology of learning and memory, 115, 43-8. doi:10.1016/j.nlm.2014.08.005. https://pubmed.ncbi.nlm.nih.gov/25150149/
3. Rahman, Z, Gold, S J, Potenza, M N, Wensel, T G, Nestler, E J. . Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 19, 2016-26. doi:. https://pubmed.ncbi.nlm.nih.gov/10066255/
4. Zhang, K, Howes, K A, He, W, Wensel, T G, Baehr, W. . Structure, alternative splicing, and expression of the human RGS9 gene. In Gene, 240, 23-34. doi:. https://pubmed.ncbi.nlm.nih.gov/10564809/
5. Psifogeorgou, Kassi, Papakosta, Paraskevi, Russo, Scott J, Gold, Stephen J, Zachariou, Venetia. 2007. RGS9-2 is a negative modulator of mu-opioid receptor function. In Journal of neurochemistry, 103, 617-25. doi:. https://pubmed.ncbi.nlm.nih.gov/17725581/
6. Gold, Stephen J, Hoang, Chau V, Potts, Bryan W, Neve, Rachael L, Bezard, Erwan. . RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 27, 14338-48. doi:. https://pubmed.ncbi.nlm.nih.gov/18160641/
智鼠故事 
